👤 Person

Eli Lilly

American pharmacist, Union Army officer, businessman, philanthropist (1838–1898)

📊 Rating

8 news mentions · 👍 0 likes · 👎 0 dislikes

📌 Topics

Pharmaceutical innovation (2)
Market Competition (1)
Pharmaceutical Industry (1)
Business Challenges (1)
Pharmaceutical Competition (1)
Clinical Trials (1)
Stock Market Reaction (1)
Obesity Treatment Market (1)
Pharmaceutical Licensing (1)
Autoimmune Disease Treatment (1)
Biotechnology Expansion (1)
Treatment efficacy (1)

🏷️ Keywords

Eli Lilly (6) · Novo Nordisk (2) · CagriSema (2) · Taltz (2) · Zepbound (2) · Psoriasis (2) · Combination therapy (2) · GLP-1 drugs (1) · Weight loss market (1) · Pricing pressure (1) · Market share (1) · Stock performance (1) · tirzepatide (1) · weight loss drug (1) · clinical trial (1) · stock market (1) · obesity treatment (1) · CSL (1) · clazakizumab (1) · licensing deal (1)

📖 Key Information

Eli Lilly (July 8, 1838 – June 6, 1898) was an American Union Army officer, pharmacist, chemist, and businessman who founded Eli Lilly and Company. Lilly enlisted in the Union Army during the American Civil War and recruited a company of men to serve with him in the 18th Independent Battery Indiana Light Artillery. He was later promoted to major and then colonel, and was given command of the 9th Indiana Infantry Regiment.

📰 Related News (8)

🇺🇸 These 4 charts show the scale of Novo Nordisk's woes (2026-02-25)
Despite being first to launch a GLP-1 drug for weight loss, Novo's market share has eroded, and the company now only captures about 40% of the market....
🇺🇸 Eli Lilly's lead in the obesity race gets wider after another win against rival Novo Nordisk (2026-02-23)
Lilly shares rose more than 4% Monday, while rival Novo Nordisk tanked....
🇺🇸 Eli Lilly launches new form of obesity drug Zepbound with a month’s worth of doses in one pen (2026-02-23)
Eli Lilly hopes the device can be more convenient for Zepbound users and lead to more people taking the drug....
🇺🇸 Novo Nordisk sinks 10% after weight loss drug fails to match Eli Lilly's in trial (2026-02-23)
Novo Nordisk stock fell as much as 10% Monday after it said its next-generation weight loss drug didn't meet its primary target....
🇺🇸 CSL signs licensing deal with Eli Lilly for clazakizumab (2026-02-18)
🇺🇸 Lilly’s taltz and zepbound combination shows superior efficacy in psoriasis (2026-02-18)
🇺🇸 Lilly's Zepbound and Taltz improve psoriasis symptoms, drive weight loss in study (2026-02-18)
Eli Lilly said on Wednesday the combined use of its weight-loss drug Zepbound with psoriasis treatment Taltz showed better results in a late-stage st...
🇺🇸 Eli Lilly plans $1 billion investment in India for global exports (2026-02-17)

🔗 Entity Intersection Graph

People and organizations frequently mentioned alongside Eli Lilly:

Novo Nordisk · 3 shared articles
Psoriasis · 2 shared articles
🌐
Ixekizumab · 2 shared articles
Tirzepatide · 2 shared articles
🌐
Combination therapy · 1 shared articles
🌐
Cagrilintide/semaglutide · 1 shared articles
Weight loss · 1 shared articles
🌐
CSL · 1 shared articles
Market share · 1 shared articles